<DOC>
	<DOCNO>NCT01444872</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , pharmacokinetics pharmacodynamics TRV120027 subject heart failure mild moderate renal dysfunction .</brief_summary>
	<brief_title>Study Evaluate TRV120027 Renal Pharmacodynamics Patients With Heart Failure Renal Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Written Informed Consent Heart Failure Mild moderate renal dysfunction Age 18 &lt; 75 Males female ( nonchildbearing potential ) Any significant disease condition would interfere interpretation safety efficacy efficacy data determine Investigator base medical history , physical examination laboratory test Any serious life threaten disease may impair interpretation safety efficacy data study determine Investigator Allergy clinicallysignificant intolerance ARBs ACE inhibitor Clinical sign symptom acute decompensated heart failure Pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>